Durable Remission of Highly Refractory Multiple Myeloma and Therapy-Related MDS/AML After Allogeneic Hematopoietic Cell Transplantation: Reconsidering Its Role in the CAR-T Era. [PDF]
Kumamoto T +7 more
europepmc +1 more source
ABSTRACT Although circulating nucleated red blood cells (cNRBCs) have previously been detected in patients with sickle cell disease (SCD), their prevalence and clinical significance during steady‐state disease have not been established. We retrospectively analyzed 270 adults with an SS or Sβ0‐thalassemia genotype.
Ugo Boccadifuoco +7 more
wiley +1 more source
Molecular Diagnosis of Early Equivocal Alloimmune Injury After Imlifidase Desensitization in a Kidney Transplant Recipient. [PDF]
Hamdini L +11 more
europepmc +1 more source
Durable Hematologic Response in Therapy-Related Myelodysplastic Syndrome During Nivolumab Treatment for Metastatic Melanoma: A Case Report. [PDF]
Hamza FNM +3 more
europepmc +1 more source
Beyond Negative Electrophoresis and Immunofixation: A Three-Case Series of Non-secretory Multiple Myeloma. [PDF]
Bentahar R +4 more
europepmc +1 more source
Malignancy of Urinary Tract in Kidney Transplant Recipients-A Narrative Review. [PDF]
Małyszko SJ +8 more
europepmc +1 more source
Direct-Acting Antiviral Therapy and Long-Term Outcomes in Dialysis Patients With Hepatitis C: A Real-world Cohort Study. [PDF]
Jiang MY, Wu JY, Lee YC, Lu TH.
europepmc +1 more source
Therapy-related myeloid neoplasms following treatment for high-risk gestational trophoblastic neoplasia: a case series and retrospective analysis. [PDF]
Niimi K +4 more
europepmc +1 more source
Related searches:
Malignant Neoplasm in Kidney Transplantation
International Journal of Urology, 1998Background: The kidney recipient is at a higher risk for cancer than is the general population, although the incidence of neoplasms in general is considered lower in Japan than in Western countries. The cause of this increased risk associated with either transplantation or geography has not yet been established.
H Kishikawa, K Yazawa
exaly +3 more sources

